<?xml version="1.0" encoding="UTF-8"?>
<drug type="biotech" created="2018-06-22" updated="2019-12-02">
  <drugbank-id primary="true">DB14115</drugbank-id>
  <name>Human botulinum neurotoxin A/B immune globulin</name>
  <description/>
  <cas-number/>
  <unii>X641Y30OA7</unii>
  <groups>
    <group>approved</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication/>
  <pharmacodynamics/>
  <mechanism-of-action/>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description/>
    <direct-parent>Peptides</direct-parent>
    <kingdom>Organic Compounds</kingdom>
    <superclass>Organic Acids</superclass>
    <class>Carboxylic Acids and Derivatives</class>
    <subclass>Amino Acids, Peptides, and Analogues</subclass>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="english" coder="">Botulism immune globulin intravenous (human)</synonym>
    <synonym language="english" coder="">Botulism immune globulin intravenous (human) (BIG-IV)</synonym>
    <synonym language="english" coder="">Botulism immune globulin IV human</synonym>
    <synonym language="english" coder="">Human-derived botulism antitoxin antibodies</synonym>
  </synonyms>
  <products>
    <product>
      <name>BabyBIG</name>
      <labeller>California Department Of Public Health</labeller>
      <ndc-id/>
      <ndc-product-code>68403-1100</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2003-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, powder, lyophilized, for solution</dosage-form>
      <strength>50 mg/1mL</strength>
      <route>Intravenous</route>
      <fda-application-number>BLA125034</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>BabyBIG</name>
      <ingredients>Human botulinum neurotoxin A/B immune globulin</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Bacterial Neurotoxin Neutralization</category>
      <mesh-id/>
    </category>
    <category>
      <category>Human Immunoglobulin G</category>
      <mesh-id/>
    </category>
    <category>
      <category>Passively Acquired Immunity</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms/>
  <dosages>
    <dosage>
      <form>Injection, powder, lyophilized, for solution</form>
      <route>Intravenous</route>
      <strength>50 mg/1mL</strength>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries/>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <sequences/>
  <experimental-properties/>
  <external-identifiers/>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>